Evidence map›Paper›PMID 34257609›Full record

ArticlePathology oncology research : POR2021

Cell Cycle Regulatory Protein Expression in Multinucleated Giant Cells of Giant Cell Tumor of Bone: do They Proliferate?

Mate E Maros, Peter Balla, Tamas Micsik, Zoltan Sapi, Miklos Szendroi, Holger Wenz, Christoph Groden, Ramses G Forsyth, Piero Picci, Tibor Krenacs

Open access · goldAbstract read
In one paragraph

Article in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Mate E Maros1 Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Peter Balla1 Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Tamas Micsik1 Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Zoltan Sapi1 Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Miklos SzendroiDepartment of Orthopedics, Semmelweis University, Budapest, Hungary.
Holger WenzDepartment of Neuroradiology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Christoph GrodenDepartment of Neuroradiology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Ramses G ForsythDepartment of Anatomic Pathology and Experimental Pathology, University Ziekenhuis, Brussels, Belgium.
Piero PicciLaboratory of Experimental Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy.
Tibor Krenacs1 Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Semmelweis University · HUIstituto Ortopedico Rizzoli · ITUniversitair Ziekenhuis Brussel · BEUniversity Hospital Heidelberg · DEUniversity Medical Centre Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells of the monocyte macrophage lineage form multinucleated giant cells (GCs) by fusion, which may express some cell cycle markers. By using a comprehensive marker set, here we looked for potential replication activities in GCs, and investigated whether these have diagnostic or clinical relevance in giant cell tumor of bone (GCTB). GC rich regions of 10 primary and 10 first recurrence GCTB cases were tested using immunohistochemistry in tissue microarrays. The nuclear positivity rate of the general proliferation marker, replication licensing, G1/S-phase, S/G2/M-phase, mitosis promoter, and cyclin dependent kinase (CDK) inhibitor reactions was analyzed in GCs. Concerning Ki67, moderate SP6 reaction was seen in many GC nuclei, while B56 and Mib1 positivity was rare, but the latter could be linked to more aggressive (

Indexed as

Cell CycleCell ProliferationAdolescentAdultAgedBiomarkers, TumorBone NeoplasmsCell Cycle ProteinsFemaleFollow-Up StudiesGiant Cell Tumor of BoneHumansMaleMiddle AgedPrognosisRetrospective StudiesBiomarkers, TumorCell Cycle Proteinscyclin D1cyclin G1giant cellsgiant cell tumor of boneKi-67p21 (CDKN1A) WAF1p53

Identifiers

PMID34257609
PMCPMC8262213
OpenAlexW3159167551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.